vs

Side-by-side financial comparison of MediWound Ltd. (MDWD) and Origin Materials, Inc. (ORGN). Click either name above to swap in a different company.

MediWound Ltd. is the larger business by last-quarter revenue ($5.7M vs $3.0M, roughly 1.9× Origin Materials, Inc.). MediWound Ltd. runs the higher net margin — -233.3% vs -6423.8%, a 6190.5% gap on every dollar of revenue. On growth, MediWound Ltd. posted the faster year-over-year revenue change (12.7% vs -67.2%).

MediWound Ltd. is a biopharmaceutical company specializing in the research, development, production and commercialization of innovative products for burn care, chronic wound treatment and soft tissue repair. It operates mainly across North America, Europe and Asia, serving hospitals, healthcare providers and patients in the wound care segment.

Origin Systems, Inc. was an American video game developer based in Austin, Texas. It was founded on March 3, 1983, by Richard Garriott and his brother Robert. Origin is best known for their groundbreaking work in multiple genres of video games, such as the Ultima and Wing Commander series. The company was purchased by Electronic Arts in 1992.

MDWD vs ORGN — Head-to-Head

Bigger by revenue
MDWD
MDWD
1.9× larger
MDWD
$5.7M
$3.0M
ORGN
Growing faster (revenue YoY)
MDWD
MDWD
+80.0% gap
MDWD
12.7%
-67.2%
ORGN
Higher net margin
MDWD
MDWD
6190.5% more per $
MDWD
-233.3%
-6423.8%
ORGN

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MDWD
MDWD
ORGN
ORGN
Revenue
$5.7M
$3.0M
Net Profit
$-13.3M
$-194.1M
Gross Margin
23.5%
Operating Margin
-100.1%
-6438.5%
Net Margin
-233.3%
-6423.8%
Revenue YoY
12.7%
-67.2%
Net Profit YoY
-111.2%
-1335.6%
EPS (diluted)
$-1.23
$-50.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDWD
MDWD
ORGN
ORGN
Q4 25
$3.0M
Q3 25
$4.7M
Q2 25
$5.7M
$5.8M
Q1 25
$5.4M
Q4 24
$9.2M
Q3 24
$8.2M
Q2 24
$5.1M
$7.0M
Q1 24
$6.8M
Net Profit
MDWD
MDWD
ORGN
ORGN
Q4 25
$-194.1M
Q3 25
$-16.4M
Q2 25
$-13.3M
$-12.7M
Q1 25
$-26.4M
Q4 24
$-13.5M
Q3 24
$-36.8M
Q2 24
$-6.3M
$-19.5M
Q1 24
$-13.9M
Gross Margin
MDWD
MDWD
ORGN
ORGN
Q4 25
Q3 25
Q2 25
23.5%
Q1 25
Q4 24
Q3 24
Q2 24
8.8%
Q1 24
Operating Margin
MDWD
MDWD
ORGN
ORGN
Q4 25
-6438.5%
Q3 25
-363.6%
Q2 25
-100.1%
-257.5%
Q1 25
-600.8%
Q4 24
-175.7%
Q3 24
-395.1%
Q2 24
-88.6%
-259.6%
Q1 24
-263.7%
Net Margin
MDWD
MDWD
ORGN
ORGN
Q4 25
-6423.8%
Q3 25
-351.8%
Q2 25
-233.3%
-219.3%
Q1 25
-486.9%
Q4 24
-146.6%
Q3 24
-448.2%
Q2 24
-124.5%
-277.3%
Q1 24
-203.9%
EPS (diluted)
MDWD
MDWD
ORGN
ORGN
Q4 25
$-50.17
Q3 25
$-0.11
Q2 25
$-1.23
$-0.09
Q1 25
$-0.18
Q4 24
$-17.04
Q3 24
$-0.26
Q2 24
$-0.68
$-0.14
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDWD
MDWD
ORGN
ORGN
Cash + ST InvestmentsLiquidity on hand
$1.1M
$32.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.1M
$104.2M
Total Assets
$67.0M
$157.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDWD
MDWD
ORGN
ORGN
Q4 25
$32.9M
Q3 25
$34.1M
Q2 25
$1.1M
$35.3M
Q1 25
$43.8M
Q4 24
$56.3M
Q3 24
$56.4M
Q2 24
$3.8M
$55.7M
Q1 24
$75.8M
Stockholders' Equity
MDWD
MDWD
ORGN
ORGN
Q4 25
$104.2M
Q3 25
$295.0M
Q2 25
$20.1M
$311.1M
Q1 25
$314.6M
Q4 24
$338.4M
Q3 24
$358.9M
Q2 24
$17.9M
$390.6M
Q1 24
$408.2M
Total Assets
MDWD
MDWD
ORGN
ORGN
Q4 25
$157.7M
Q3 25
$327.3M
Q2 25
$67.0M
$348.4M
Q1 25
$349.0M
Q4 24
$378.0M
Q3 24
$399.6M
Q2 24
$57.3M
$431.0M
Q1 24
$448.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDWD
MDWD
ORGN
ORGN
Operating Cash FlowLast quarter
$-5.8M
$-8.9M
Free Cash FlowOCF − Capex
$-18.0M
FCF MarginFCF / Revenue
-596.6%
Capex IntensityCapex / Revenue
301.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-63.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDWD
MDWD
ORGN
ORGN
Q4 25
$-8.9M
Q3 25
$-8.1M
Q2 25
$-5.8M
$-7.3M
Q1 25
$-8.4M
Q4 24
$-5.7M
Q3 24
$-13.4M
Q2 24
$-3.6M
$-15.0M
Q1 24
$-16.7M
Free Cash Flow
MDWD
MDWD
ORGN
ORGN
Q4 25
$-18.0M
Q3 25
$-13.5M
Q2 25
$-16.0M
Q1 25
$-15.4M
Q4 24
$-9.5M
Q3 24
$-16.0M
Q2 24
$-15.6M
Q1 24
$-18.7M
FCF Margin
MDWD
MDWD
ORGN
ORGN
Q4 25
-596.6%
Q3 25
-290.5%
Q2 25
-275.4%
Q1 25
-284.2%
Q4 24
-103.5%
Q3 24
-194.7%
Q2 24
-221.8%
Q1 24
-273.6%
Capex Intensity
MDWD
MDWD
ORGN
ORGN
Q4 25
301.4%
Q3 25
115.7%
Q2 25
149.9%
Q1 25
128.8%
Q4 24
41.6%
Q3 24
31.0%
Q2 24
9.0%
Q1 24
28.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons